查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949549

即時診斷市場－全球產業規模、佔有率、趨勢、機會及預測（按產品、平台、購買模式、最終用戶、地區和競爭格局分類，2021-2031年）

Point of Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Platform, By Mode Of Purchase, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球照護現場診斷市場預計將從 2025 年的 498.9 億美元成長到 2031 年的 848.3 億美元，複合年成長率為 9.25%。

該市場定義為在患者附近進行、無需依賴中心檢查室基礎設施即可快速獲得結果的醫學檢測。其主要驅動力是全球慢性病和感染疾病的日益增多，這些疾病需要即時做出臨床決策以改善患者預後。此外，對分散式醫療服務的需求不斷成長，也推動了這些診斷解決方案在非醫院環境（例如居家醫療保健和遠距診所）的普及。

市場概覽
預測期 2027-2031
市場規模：2025年 498.9億美元
市場規模：2031年 848.3億美元
複合年成長率：2026-2031年 9.25%
成長最快的細分市場 橫向流動化驗
最大的市場 北美洲

然而，由於嚴格的法規結構，包括高昂的合規成本和漫長的產品商業化週期，市場面臨許多挑戰。這種複雜的核准流程對尋求引進新技術的製造商構成了巨大的財務障礙。例如，根據歐洲醫療技術協會（MedTech Europe）報告，到2024年，根據體外診斷醫療設備法規，品管系統認證的平均成本將達到108,307歐元。這些不斷上漲的營運成本可能會限制小規模診斷設備開發商的進入，從而扼殺創新並阻礙​​市場擴張。

市場促進因素

微流體和生物感測器技術的進步正在從根本上改變全球照護現場診斷市場，使患者能夠在床邊直接進行檢查室層級的分子檢測。這些創新能夠以高靈敏度快速檢測複雜病原體，從而減少對集中式基礎設施的依賴，並加速治療啟動。自動化平台的整合尤其迅速成長，這主要得益於對可在傳統醫院實驗室之外部署的精準呼吸系統診斷的需求。例如，丹納赫公司旗下的Sepede部門在其2024年第三季公佈財報上報告稱，其呼吸系統診斷產品創造了4.25億美元的收入，凸顯了先進分子技術在維持市場成長勢頭方面發揮的關鍵作用。

此外，全球慢性病和感染疾病率上升是市場擴張的主要驅動力，亟需獲得及時的臨床洞察以減輕嚴重的健康後果。隨著糖尿病等慢性病日益普遍，患者越來越依賴持續監測解決方案來輔助自我管理，並減輕急診機構的負擔。值得注意的是，雅培在「2024年第三季財報」新聞稿中指出，持續血糖監測系統的廣泛應用推動了該公司糖尿病護理部門19.1%的有機銷售額成長。羅氏的情況更為明顯，其診斷部門2024年的銷售額以固定外匯計算成長了4%，反映出全球對免疫診斷和臨床化學檢測的持續需求。

市場挑戰

嚴格的法律規範是全球照護現場診斷市場成長的主要障礙，因為它們會帶來高昂的合規成本並延緩產品商業化進程。這些嚴格的核准流程要求製造商投入大量資源進行全面的臨床試驗和編寫詳細的技術文檔，從而佔用了原本可用於研發的資金。沉重的合規負擔顯著延長了新檢測方案的上市時間，延遲了產生收入，並造成了瓶頸，這對缺乏足夠流動資金來應對長期無收入期的中小型開發商尤為不利。

這些監管障礙的影響顯而易見，它們減緩了創新和市場准入的步伐。面對難以預測的認證時間表，製造商常常推遲或取消在關鍵地區的產品上市，這直接阻礙了市場擴張。根據歐洲醫療技術協會（MedTech Europe）預測，到2024年，這些實施方面的挑戰將導致領先的體外診斷設備製造商選擇歐盟作為其主要上市地區的意願下降40%。這項數據表明，新型診斷設備的普及率明顯下降，證實了過度監管要求正在限制基本醫療檢測的普及，並減緩整體市場成長。

市場趨勢

整合人工智慧 (AI) 和機器學習的自動化結果解讀技術正在顯著推動全球照護現場診斷市場的發展，其顯著提升了診斷準確性並簡化了臨床工作流程。這些技術被整合到診斷平台中，以實現複雜生物數據的自動化分析，最大限度地減少人為錯誤，並使非專業人員能夠在分散式環境中執行進階檢測。監管方面的進步也為這項技術變革提供了支持。正如 MedTech Dive 在 2024 年 10 月報導的那樣，截至 2024 年 8 月，美國食品藥物管理局(FDA)核准了950 種搭載人工智慧或機器學習技術的醫療設備，使製造商能夠部署提供即時臨床決策支援的智慧工具。

同時，零售診所和藥局就地檢驗的日益普及正在改變醫療服務模式，在傳統醫院體系之外建立了一條便捷的「檢測即治療」路徑。大型連鎖藥局正積極拓展服務範圍，將基層醫療診所和診斷中心直接整合到其零售門市網路中，以滿足消費者對便利性就診服務的需求。這一策略轉變正在推動財務成長。根據沃博聯（Walgreens Boots Alliance）2024會計年度財報，該公司美國醫療保健部門第四季營收達21億美元，較去年同期成長7.1%。這印證了消費者對能夠提供即時檢測結果並與後續醫療服務無縫銜接的分散式檢查點的偏好。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球即時診斷市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（血糖監測產品、心血管代謝監測產品、傳染病檢查產品、凝血監測產品、COVID-19 檢測產品、其他）
    • 依平台分類（橫向流動化驗、試紙條檢測、微流體、分子診斷、免疫檢測）
    • 按購買方式（處方箋藥、非處方藥）
    • 依最終使用者（醫院/診所、門診手術中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美即時診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲即時診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區即時診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲即時診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲即時診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球即時診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • EKF Diagnostics
  • Abbott Laboratories Inc.
  • Siemens Healthineers Ag
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Biomerieux SA
  • Chembio Diagnostics, Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23497

The Global Point of Care Diagnostics Market is projected to expand from USD 49.89 Billion in 2025 to USD 84.83 Billion by 2031, registering a compound annual growth rate of 9.25%. Defined as medical testing conducted near the patient to deliver rapid results independent of central laboratory infrastructure, this market is primarily driven by the increasing global prevalence of chronic and infectious diseases that require immediate clinical decision-making to improve patient outcomes. Furthermore, the rising demand for decentralized healthcare services supports the widespread adoption of these diagnostic solutions in non-hospital environments, such as home care settings and remote clinics.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 49.89 Billion
Market Size 2031USD 84.83 Billion
CAGR 2026-20319.25%
Fastest Growing SegmentLateral Flow Assays
Largest MarketNorth America

However, the market confronts significant challenges due to stringent regulatory frameworks that mandate high compliance costs and prolong product commercialization. These complex approval processes establish substantial financial barriers for manufacturers attempting to introduce new technologies. For instance, MedTech Europe reported that in 2024, the average fee for Quality Management System certification under the In Vitro Diagnostic Regulation was 108,307 euros. Such elevated operational expenses can stifle innovation and hinder market expansion by restricting the participation of smaller diagnostic developers.

Market Driver

Technological advancements in microfluidics and biosensors are fundamentally transforming the Global Point of Care Diagnostics Market by facilitating laboratory-quality molecular testing directly at the patient's bedside. These innovations enable the rapid detection of complex pathogens with high sensitivity, reducing dependence on centralized infrastructure and accelerating treatment initiation. The integration of automated platforms has seen a particular surge, driven by the need for precise respiratory diagnostics deployable outside traditional hospital labs; for example, Danaher Corporation's Cepheid division reported in its 'Third Quarter 2024 Earnings Release' that respiratory product diagnostics generated $425 million in revenue, highlighting the critical role of advanced molecular technologies in maintaining market momentum.

Additionally, the rising global incidence of chronic and infectious diseases acts as a primary catalyst for market expansion, necessitating immediate clinical insights to mitigate severe health outcomes. As chronic conditions like diabetes escalate, there is a growing reliance on continuous monitoring solutions that empower patient self-management and relieve pressure on emergency facilities. Notably, Abbott's 'Abbott Reports Third-Quarter 2024 Results' press release indicated that sales in its Diabetes Care division grew by 19.1 percent on an organic basis due to the widespread adoption of continuous glucose monitoring systems. This demand for effective disease management tools is further evidenced by Roche, where Diagnostics Division sales increased by 4 percent at constant exchange rates in 2024, reflecting sustained global demand for immunodiagnostic and clinical chemistry testing.

Market Challenge

Stringent regulatory frameworks impose substantial compliance costs and delay product commercialization, presenting a formidable obstacle to the growth of the Global Point of Care Diagnostics Market. These rigorous approval processes require manufacturers to allocate extensive resources to comprehensive clinical trials and detailed technical documentation, diverting capital away from research and development. This heavy compliance burden significantly extends the time-to-market for new testing solutions, creating a bottleneck that postpones revenue generation and discourages investment in novel technologies, particularly affecting smaller developers who lack the liquidity to endure prolonged non-revenue periods.

The impact of these regulatory hurdles is evident in the reduced pace of innovation and market entry. Faced with unpredictable certification timelines, manufacturers often delay or cancel product launches in key regions, which directly stalls market expansion. According to MedTech Europe, the preference for the European Union as a primary launch geography dropped by 40% among large in vitro diagnostic manufacturers in 2024 due to these implementation challenges. This statistic demonstrates a clear contraction in the deployment of new diagnostics, confirming that excessive regulatory demands are actively restricting the availability of essential medical testing and dampening overall market growth.

Market Trends

The integration of Artificial Intelligence and Machine Learning for Automated Result Interpretation is significantly advancing the Global Point of Care Diagnostics Market by improving diagnostic accuracy and streamlining clinical workflows. These technologies are increasingly embedded in diagnostic platforms to automate the analysis of complex biological data, minimizing human error and enabling non-specialized personnel to perform sophisticated testing in decentralized settings. This technological shift is supported by regulatory momentum; as noted by MedTech Dive in October 2024, the U.S. Food and Drug Administration had authorized a cumulative total of 950 AI or machine learning-enabled medical devices by August 2024, allowing manufacturers to deploy smart tools that provide real-time clinical decision support.

Simultaneously, the rising utilization of point-of-care testing in retail clinics and pharmacies is transforming healthcare delivery by establishing accessible "test-to-treat" pathways outside of traditional hospital infrastructure. Major pharmacy chains are aggressively expanding their service portfolios, integrating primary care clinics and diagnostic hubs directly into their retail footprints to capture the demand for convenient, walk-in medical services. This strategic pivot is yielding financial growth; according to the Walgreens Boots Alliance 'Fiscal Year 2024 Earnings' report, the company's U.S. Healthcare segment generated fourth-quarter sales of $2.1 billion, a 7.1 percent increase over the prior year, underscoring consumer preference for decentralized testing locations that offer immediate results and seamless connections to treatment.

Key Market Players

  • EKF Diagnostics
  • Abbott Laboratories Inc.
  • Siemens Healthineers Ag
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Biomerieux S.A.
  • Chembio Diagnostics, Inc

Report Scope

In this report, the Global Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Point of Care Diagnostics Market, By Product

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring products
  • Covid-19 Test Products
  • Others

Point of Care Diagnostics Market, By Platform

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Point of Care Diagnostics Market, By Mode Of Purchase

  • Prescription Based Products
  • OTC Products

Point of Care Diagnostics Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Point of Care Diagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Point of Care Diagnostics Market.

Available Customizations:

Global Point of Care Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Point of Care Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring products, Covid-19 Test Products, Others)
    • 5.2.2. By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays)
    • 5.2.3. By Mode Of Purchase (Prescription Based Products, OTC Products)
    • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Point of Care Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Platform
    • 6.2.3. By Mode Of Purchase
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Point of Care Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Platform
        • 6.3.1.2.3. By Mode Of Purchase
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Point of Care Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Platform
        • 6.3.2.2.3. By Mode Of Purchase
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Point of Care Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Platform
        • 6.3.3.2.3. By Mode Of Purchase
        • 6.3.3.2.4. By End User

7. Europe Point of Care Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Platform
    • 7.2.3. By Mode Of Purchase
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Point of Care Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Platform
        • 7.3.1.2.3. By Mode Of Purchase
        • 7.3.1.2.4. By End User
    • 7.3.2. France Point of Care Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Platform
        • 7.3.2.2.3. By Mode Of Purchase
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Point of Care Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Platform
        • 7.3.3.2.3. By Mode Of Purchase
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Point of Care Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Platform
        • 7.3.4.2.3. By Mode Of Purchase
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Point of Care Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Platform
        • 7.3.5.2.3. By Mode Of Purchase
        • 7.3.5.2.4. By End User

8. Asia Pacific Point of Care Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Platform
    • 8.2.3. By Mode Of Purchase
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Point of Care Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Platform
        • 8.3.1.2.3. By Mode Of Purchase
        • 8.3.1.2.4. By End User
    • 8.3.2. India Point of Care Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Platform
        • 8.3.2.2.3. By Mode Of Purchase
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Point of Care Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Platform
        • 8.3.3.2.3. By Mode Of Purchase
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Point of Care Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Platform
        • 8.3.4.2.3. By Mode Of Purchase
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Point of Care Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Platform
        • 8.3.5.2.3. By Mode Of Purchase
        • 8.3.5.2.4. By End User

9. Middle East & Africa Point of Care Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Platform
    • 9.2.3. By Mode Of Purchase
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Point of Care Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Platform
        • 9.3.1.2.3. By Mode Of Purchase
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Point of Care Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Platform
        • 9.3.2.2.3. By Mode Of Purchase
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Point of Care Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Platform
        • 9.3.3.2.3. By Mode Of Purchase
        • 9.3.3.2.4. By End User

10. South America Point of Care Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Platform
    • 10.2.3. By Mode Of Purchase
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Point of Care Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Platform
        • 10.3.1.2.3. By Mode Of Purchase
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Point of Care Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Platform
        • 10.3.2.2.3. By Mode Of Purchase
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Point of Care Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Platform
        • 10.3.3.2.3. By Mode Of Purchase
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Point of Care Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. EKF Diagnostics
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Abbott Laboratories Inc.
  • 15.3. Siemens Healthineers Ag
  • 15.4. F. Hoffmann-La Roche Ltd
  • 15.5. Quidel Corporation
  • 15.6. Danaher Corporation
  • 15.7. Becton, Dickinson and Company
  • 15.8. Thermo Fisher Scientific Inc
  • 15.9. Biomerieux S.A.
  • 15.10. Chembio Diagnostics, Inc

16. Strategic Recommendations

17. About Us & Disclaimer